Skip to main content
Start triage

Start triage first, then route to emergency care.

Need urgent help? Start triage first, then route to emergency care.

Roxee Medication Guide

Prednisone

Medication reference facts with explicit FDA-approval, off-label, source-limited, and safety context. Roxee does not sell, prescribe, or dispense medications.

Both Reference complete FDA data linked Rx required Liquid (Suspension) Intervet, Inc. Official label facts Owner quick guide first

Veterinary professional?

Showing simplified owner view. Switch to Vet View for full technical detail.

Data freshness

Reference facts
Reference refreshed
Aug 6, 2026, 7:46 p.m.

These are the reference facts Roxee uses on browse cards and quick facts.

FDA applications
FDA application data refreshed
Aug 6, 2026, 7:46 p.m.

Sponsor, product, and application records imported from Animal Drugs @ FDA.

Safety reports
Safety data refreshed
Aug 6, 2026, 7:49 p.m.

openFDA reaction terms and case summaries are supporting evidence, not proof of causality.

Source timing details
Source timing details
  • Reference facts: Source Roxee | Refreshed Aug 6, 2026, 7:46 PM UTC
    The reference fact projection used for browse cards and quick facts.
  • Animal Drugs @ FDA: Source FDA | Refreshed Aug 6, 2026, 7:46 PM UTC
    Applications/products are imported from FDA export data.
  • Animal Drugs @ FDA previews: Source FDA | Refreshed Feb 9, 2026, 3:05 AM UTC
    Label highlights/doc links are fetched from FDA preview endpoints.
  • openFDA reaction terms: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
  • openFDA case summaries: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
Illustration placeholder
Prednisone

Prednisone

Drug type: Generic ingredient • Generic profile No FDA branded products linked

Both Liquid (Suspension) Rx required 100% reference complete

Species: Both

Manufacturer: Intervet, Inc.

Medication Snapshot

Merged from the current Roxee medication system with field-level provenance, freshness, and completeness tracking.

Prednisone

Corticosteroid used for inflammatory and immune-mediated conditions. Species commonly shown: Both, Dog, Restricted During Pregnancy, Horse, Restricted During Pregnancy.

Generic name
Prednisone
Brand names
Meticorten®
Manufacturer
Intervet, Inc.
Species
Both, Dog, Horse, Cat
Dosage forms
Liquid (Suspension)
Prescription
Prescription required
Completeness
100%
Validation
Complete
Brand names
Meticorten®
Dosage forms
Liquid (Suspension)

Indications / Uses

Corticosteroid used for inflammatory and immune-mediated conditions.

Administration / How To Give

Oral

Storage

Store at room temperature.

Warnings / Contraindications

Avoid combining with NSAIDs. Use caution with diabetes, infections, GI ulcer history.

  • Avoid combining with NSAIDs. Use caution with diabetes, infections, GI ulcer history.

Side Effects

Increased thirst/urination, increased appetite, panting, GI upset. Long-term use: immune suppression and other risks.

FAQ

Both, Dog, Restricted During Pregnancy, Horse, Restricted During Pregnancy, Horse, Not For Meat Production, Cat, Restricted During Pregnancy

Yes. Roxee shows this as prescription-only.

Liquid (Suspension)

Store at room temperature.

Related Conditions

Source Transparency

Add to My Pet's Medications

Choose a pet, confirm current or past, and optionally add reminder notes.

Sign in to save this medication to your pet profile.

Sign in to continue

Pet Owner Quick Guide

Start here first for the safest next-step summary before the deeper medication detail.

Used for:

It is used for conditions requiring an anti-inflammatory agent.

Dosing note:

Exact dosing depends on your pet's species, weight, and health status. Use your veterinarian's instructions for the exact dose and schedule.

What to watch for:

  • Avoid combining with NSAIDs
  • Use caution with diabetes, infections, GI ulcer history
  • wobbly/unsteady walking (1 reports)
  • Loss of appetite (1 reports)
  • Blood in urine (1 reports)

When to call the vet:

  • Repeated vomiting or diarrhea.
  • Severe lethargy (hard to wake, very low energy).
  • Collapse or fainting.
  • Trouble breathing.
  • Facial swelling or hives.
  • Blood in vomit or stool.

What to tell or ask your vet today:

  • Is this medicine the right fit for my pet’s current symptoms?
  • Which warning signs mean I should call back right away?
  • How should I handle missed doses or refusal to take the medicine?

Next actions

Research brief

Medication Research Insights

A source-aware map of what to know, what is uncertain, and what to verify with your veterinarian.

Source Backed Signals

What to know

Evidence-backed context Limited

Roxee has limited cited overview evidence for Prednisone; use the official documents and your veterinarian's instructions for product-specific decisions.

Source: openFDA case USA-USFDACVM-2026-US-014449
Safety signal coverage Reported signals

32 tracked reaction signals; 32 reported cases; 19 serious reports; 2 species groups. These are reporting and label-derived signals for interpretation with a veterinarian.

Source: openFDA case USA-USFDACVM-2026-US-014449
Interpretation guardrail Not causation

Adverse-event reports help form a watch list, but they do not prove the medication caused the reaction and they are not a risk ranking between medications.

Evidence tension

Stronger signal Label / review

Official labels, package inserts, and reviewed summaries carry more weight than isolated reports.

Source: openFDA case USA-USFDACVM-2026-US-014449
Weaker signal Reported data

Case reports and openFDA terms are useful for pattern awareness, but they are incomplete, can include multiple exposures, and do not estimate an individual pet's probability of harm.

Reaction signal map

Most reported reactions Top terms

Unsteady walking (ataxia) (1 reports), Loss of appetite (1 reports), Blood in urine (1 reports), Blood in faeces (1 reports), Aspiration pneumonia (1 reports)

Body systems represented Signal grouping

Digestive (2), Skin & allergy (3), Neurologic (1), Behavior (2)

Explore supporting adverse reports

Species and breed lens

Species represented in reports Species lens

Dog (23 reports), Cat (9 reports)

Breed metadata in reports Metadata only

Schnauzer - Miniature (1), Chihuahua (1), ['Shepherd Dog - Australian', 'Dog (unknown)'] (1), Retriever - Labrador (1). These are report metadata, not proof that a breed is at higher risk.

What your vet may verify

Fit for this patient Vet check

Verify whether Prednisone fits the pet's species, current diagnosis, age, weight, organ status, pregnancy/lactation status, and concurrent medications.

Evidence limitations Evidence review

Separate label-backed warnings from adverse-event reports and owner observations before changing the plan.

What to watch next

Watch list Owner-safe

Avoid combining with NSAIDs, Use caution with diabetes, infections, GI ulcer history, wobbly/unsteady walking, Loss of appetite, Blood in urine

Call sooner if Escalation

Repeated vomiting or diarrhea. Severe lethargy (hard to wake, very low energy). Collapse or fainting.

Bottom line: Use this Prednisone brief as a structured watch list and source map, not as a reason to start, stop, or change treatment without your veterinarian.
Vet source depth
  1. openFDA case USA-USFDACVM-2026-US-014449 · adverse_reaction · adverse reactions
  2. Contraindication source · fda_animal_drugs · warnings contraindications
  3. FDA application profile · official_label · quick facts
  4. Medication usage source · fda_animal_drugs · quick facts
  5. SPL · document · documents

Evidence

Review status / Updated / Sources

Review status: Clinical reviewer not listed

Updated: February 12, 2026, 7:40 PM UTC

Sources:
Safety & side effects

Side effects to monitor:

  • Avoid combining with NSAIDs
  • Use caution with diabetes, infections, GI ulcer history
  • wobbly/unsteady walking
  • Loss of appetite
  • Blood in urine

Most reported reactions:

  • Unsteady walking (ataxia) (1 reports)
  • Loss of appetite (1 reports)
  • Blood in urine (1 reports)
Explore reported case details

Emergency warning signs:

  • Repeated vomiting or diarrhea.
  • Severe lethargy (hard to wake, very low energy).
  • Collapse or fainting.
  • Trouble breathing.

Vet Fast Scan

Source-backed clinical checkpoints for quick review.

FDA-labeled species
Cat, Dog, Horse
Indication / use
It is used for conditions requiring an anti-inflammatory agent.
Form / route / dose
Form: Liquid (Suspension)
Route: Intramuscular
Confirm product label and patient-specific plan.
Warnings
  • High: Avoid combining with NSAIDs. Use caution with diabetes, infections, GI ulcer history.
Adverse-event caveat
openFDA adverse-event cases are reported signals. They are not verified, do not prove causation, and do not estimate a pet's individual risk.
Source docs

Quick Facts

Official label facts first, then secondary summaries. Marketing content is separated below.

Species: Both
Manufacturer: Intervet, Inc.
Form: Liquid (Suspension)
Identifiers:
NADA: 9963
Source metadata:

Warnings / Contraindications

Avoid combining with NSAIDs. Use caution with diabetes, infections, GI ulcer history.

  • High: Avoid combining with NSAIDs. Use caution with diabetes, infections, GI ulcer history.
Source metadata:

Adverse Reactions

Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.

Reported case explorer

Filter stored openFDA reports by pet and report attributes. Counts describe reports in this data set, not risk.

Clear filters
openFDA adverse-event cases are reported signals. They are not verified, do not prove causation, and do not estimate a pet's individual risk.
Stored reports
66
Matching reports
18
Active filters
1
Selected filters
Body system: Skin & allergy Clear
Reset
Showing up to 50 matching reports.

USA-USFDACVM-2026-US-013826

Received 2026-03-24 · MSK · MSK

Serious
Species
Dog
Breed
Chihuahua
Size / weight
Under 10 lb (4.173 Kilogram)
Age
8+ years (12 Year)
Sex
Female Unknown
Region
USA
Reactions
Luxation/subluxationLack of efficacy - NOSJoint swellingBone and joint disorder NOSPain NOSLamenessHyperextension
Body systems
OtherEffectivenessSkin & allergy
Outcomes
Ongoing

USA-USFDACVM-2026-US-013484

Received 2026-03-20 · MSK · MSK

Serious
Species
Dog
Breed
Retriever - Labrador
Size / weight
50-99 lb (28.576 Kilogram)
Age
8+ years (1 Year)
Sex
Male Neutered
Region
USA
Reactions
LimpingLimb weaknessCoughNeurological signs NOSWobblinessCollapse NOS (see also Cardio-vascular and Neurological disorders)FeverJoint painJoint swellingGait abnormalityTense musclesElevated alanine aminotransferase (ALT)Elevated serum alkaline phosphatase (ALP)HyperglycaemiaNeutrophiliaAbnormal radiograph findingImmune-mediated polyarthritisBlood in faecesMedication error NOS
Body systems
OtherNeurologicSkin & allergy
Outcomes
Ongoing

USA-USFDACVM-2026-US-014481

Received 2026-03-19 · MSK · MSK

Serious
Species
Dog
Breed
Poodle - Standard
Size / weight
25-49 lb (18.552 Kilogram)
Age
4-7 years (6 Year)
Sex
Female Unknown
Region
USA
Reactions
DroolingNauseaInjection site swelling
Body systems
DigestiveSkin & allergy
Outcomes
Ongoing

USA-USFDACVM-2026-US-012895

Received 2026-03-19 · MSK · MSK

Serious
Species
Dog
Breed
Shepherd Dog - German
Size / weight
50-99 lb (30.844 Kilogram)
Age
4-7 years (4 Year)
Sex
Female Unknown
Region
USA
Reactions
Injection site painInjection site swellingEmesis (multiple)Decreased appetitePica NOSLocalised pain NOS (see other SOCs for specific pain)Eosinophilia
Body systems
OtherSkin & allergyDigestive
Outcomes
Ongoing

USA-USFDACVM-2026-US-012606

Received 2026-03-16 · MSK · MSK

Non-serious
Species
Cat
Breed
Domestic Shorthair
Size / weight
10-24 lb (6.98 Kilogram)
Age
4-7 years (7 Year)
Sex
Male Neutered
Region
USA
Reactions
PruritusSkin irritationNeutropeniaElevated liver enzymes NOSLeukopenia NOS
Body systems
Skin & allergyOther
Outcomes
Outcome Unknown

USA-USFDACVM-2026-US-012110

Received 2026-03-16 · MSK · MSK

Non-serious
Species
Dog
Breed
Shar Pei
Size / weight
50-99 lb (32.7 Kilogram)
Age
8+ years (11 Year)
Sex
Female Neutered
Region
USA
Reactions
ArthritisDecreased appetiteHigh sodium-potassium ratio (Na:K ratio)VomitingDiarrhoeaGait abnormalityAppetite disorder NOSStiffness NOSNot defecatingWeight lossDysorexiaHair loss NOSWeaknessMuscle wastingDistension of abdomenPolyuriaDehydrationShakingShiveringTremorGreasy skinHair sheddingAnxiety
Body systems
OtherDigestiveSkin & allergyNeurologicBehavior
Outcomes
Recovered/Normal

USA-USFDACVM-2026-US-011996

Received 2026-03-13 · MSK · MSK

Serious
Species
Dog
Breed
Terrier - Bull - American Pit
Size / weight
50-99 lb (29.937 Kilogram)
Age
4-7 years (5 Year)
Sex
Male Neutered
Region
USA
Reactions
Injection site painAnorexiaFeverInjection site swellingInjection site abscessLethargy (see also Central nervous system depression in Neurological)
Body systems
OtherDigestiveSkin & allergyNeurologic
Outcomes
Ongoing

USA-USFDACVM-2026-US-012599

Received 2026-03-12 · MSK · MSK

Serious
Species
Dog
Breed
Bulldog - English
Size / weight
50-99 lb (22.68 Kilogram)
Age
4-7 years (4 Year)
Sex
Female Neutered
Region
USA
Reactions
Head tremorFly biting behaviourLack of efficacy - NOSPolydipsiaPruritusPolyuriaPyodermaElevated blood urea nitrogen (BUN)Urinary tract infectionProteinuriaHaematuria
Body systems
NeurologicBehaviorEffectivenessOtherSkin & allergy
Outcomes
Outcome Unknown

USA-USFDACVM-2026-US-008762

Received 2026-02-19 · MSK · MSK

Serious
Species
Dog
Breed
['Retriever - Labrador', 'Crossbred Canine/dog']
Age
1-3 years (2.25 Year)
Sex
Male Neutered
Region
USA
Reactions
DiarrhoeaLack of efficacy (endoparasite) - heartwormOtitis NOSCystitisCrustPruritus
Body systems
DigestiveEffectivenessOtherSkin & allergy
Outcomes
Outcome Unknown

USA-USFDACVM-2026-US-010643

Received 2026-02-12 · MSK · MSK

Non-serious
Species
Dog
Breed
Retriever - Golden
Size / weight
50-99 lb (30.844 Kilogram)
Age
4-7 years (6 Year)
Sex
Female Unknown
Region
USA
Reactions
Localised pain NOS (see other SOCs for specific pain)Limb non-weight bearingSwollen limbWhiningUncomfortablePain NOSReluctant to moveInappropriate urinationAbnormal urine odourInjection site bleedingAnorexiaInjection site itchingInjection site irritationInjection site self traumaLimpingInjection site discharge NOSSkin irritationReddening of the skinAlopecia localInjection site scratchingInjection site swellingInjection site hair loss
Body systems
OtherDigestiveSkin & allergy
Outcomes
Outcome Unknown

USA-USFDACVM-2025-US-075299

Received 2025-12-29 · MSK · MSK

Non-serious
Species
Cat
Breed
Domestic Shorthair
Sex
Male Unknown
Region
USA
Reactions
Not eatingBalance impairedApplication site hair lossApplication site scab
Body systems
OtherSkin & allergy
Outcomes
Recovered/Normal

USA-USFDACVM-2025-US-075064

Received 2025-12-23 · MSK · MSK

Non-serious
Species
Dog
Breed
Terrier - Boston
Size / weight
10-24 lb (8.16 Kilogram)
Age
1-3 years (2 Year)
Sex
Female Neutered
Region
USA
Reactions
RashAlopecia
Body systems
Skin & allergy
Outcomes
Ongoing

USA-USFDACVM-2025-US-072787

Received 2025-12-15 · MSK · MSK

Serious
Species
Dog
Breed
Poodle - Standard
Size / weight
25-49 lb (20.412 Kilogram)
Age
1-3 years (2 Year)
Sex
Female Intact
Region
USA
Reactions
Death by euthanasiaConjunctivitisUlceration NOSEar canal erythemaWeltBumps on skinSkin inflammation NOSAnorexiaPain NOSDifficulty to risePyodermaAbnormal histology NOSSeizure NOSNeutropeniaMonocytosisElevated creatinineThrombocytopeniaHyperkeratosisPruritus
Body systems
OtherDigestiveNeurologicSkin & allergy
Outcomes
Euthanized

USA-USFDACVM-2025-US-074897

Received 2025-12-12 · MSK · MSK

Serious
Species
Dog
Breed
['Chihuahua', 'Dog (unknown)']
Size / weight
Under 10 lb (2.26 Kilogram)
Age
Under 1 year (2 Week)
Sex
Female Intact
Region
USA
Reactions
IcterusDeathOther abnormal test result NOSElevated liver enzymes NOSSwollen jointLocalised hair lossSkin lesion NOSConjunctival oedemaCorneal oedemaSkin scabSwollen limbLethargy (see also Central nervous system depression in Neurological)AnorexiaEar infection NOSLocal swelling (not application site)
Body systems
OtherSkin & allergyNeurologicDigestive
Outcomes
Died

USA-USFDACVM-2025-US-070459

Received 2025-11-25 · MSK · MSK

Serious
Species
Dog
Breed
Dachshund - Miniature
Size / weight
10-24 lb (5.557 Kilogram)
Age
4-7 years (4 Year)
Sex
Female Unknown
Region
USA
Reactions
Emesis (multiple)Lateral recumbencyPale mucous membraneDry mucous membraneAnaphylaxisHives (see also Skin)Swollen muzzle
Body systems
DigestiveOtherSkin & allergy
Outcomes
Recovered/Normal

USA-USFDACVM-2025-US-074320

Received 2025-11-24 · MSK · MSK

Serious
Species
Dog
Breed
['Terrier (unspecified)', 'Dog (unknown)']
Size / weight
25-49 lb (18.14 Kilogram)
Age
8+ years (9 Year)
Sex
Male Neutered
Region
USA
Reactions
Behavioural disorder NOSEpidermal collaretteHepatic toxicosisDermal thickeningPyodermaJoint swellingLocal swelling (not application site)Skin ulcerLethargy (see also Central nervous system depression in Neurological)ItchingHair loss NOSDeathInappetence
Body systems
BehaviorOtherSkin & allergyNeurologic
Outcomes
Died

USA-USFDACVM-2025-US-074135

Received 2025-11-20 · MSK · MSK

Serious
Species
Dog
Breed
Retriever - Labrador
Size / weight
50-99 lb (28.576 Kilogram)
Age
8+ years (12 Year)
Sex
Male Neutered
Region
USA
Reactions
Application site dry skinLack of efficacy (neoplasia, no remission)Injection site hair lossInjection site scabMast cell tumourLocal swelling (not application site)Swollen eye
Body systems
OtherEffectivenessSkin & allergy
Outcomes
Outcome Unknown

USA-USFDACVM-2025-US-068424

Received 2025-11-17 · MSK · MSK

Serious
Species
Dog
Breed
['Terrier (unspecified)', 'Dog (unknown)']
Size / weight
25-49 lb (18.14 Kilogram)
Age
8+ years (9 Year)
Sex
Male Neutered
Region
USA
Reactions
Behavioural disorder NOSEpidermal collaretteHepatic toxicosisDermal thickeningPyodermaJoint swellingLocal swelling (not application site)Skin ulcerLethargy (see also Central nervous system depression in Neurological)ItchingHair loss NOSDeathInappetence
Body systems
BehaviorOtherSkin & allergyNeurologic
Outcomes
Died

Tap or hover a reaction to see what it means in plain language.

Tracked signals
32
Reported cases
32
Serious reports
19
Species represented
2
Grouped by Body System
Digestive (2) · Loss of appetite, Appetite disorder NOS Skin & allergy (3) · Hair loss, Application site hair loss, Alopecia local Neurologic (1) · Unsteady walking (ataxia) Behavior (2) · Behavioral disorder (unspecified), Anxiety Other (24) · Blood in urine, Blood in faeces, Blepharitis
Most Reported Reactions
Reaction Body system Cases Species Serious cases
Neurologic 1 Dog 1
Digestive 1 Dog 1
Other 1 Dog 1
Other 1 Dog 1
Other 1 Dog 1
Other 1 Dog 1
Other 1 Dog 1
Other 1 Dog 1

Species coverage: Dog (23) Cat (9)

View detailed reaction table
Reaction Body system Species Seriousness Frequency Reports
Neurologic Dog Serious - 1
Digestive Dog Serious - 1
Skin & allergy Dog Non-serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Non-serious - 1
Behavior Cat Non-serious - 1
Other Cat Non-serious - 1
Other Dog Non-serious - 1
Other Dog Serious - 1
Other Dog Non-serious - 1
Other Cat Non-serious - 1
Skin & allergy Cat Non-serious - 1
Other Dog Serious - 1
Digestive Dog Non-serious - 1
Behavior Dog Non-serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Skin & allergy Dog Non-serious - 1
Other Dog Non-serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Other Dog Non-serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Source metadata:

Storage & Handling

Store at room temperature.

Source Documents

The most useful source links appear first; full previews and metadata stay in the veterinary/professional layer.

Use original documents to confirm product-specific warnings, ingredients, and handling details with your veterinarian.

Full source previews and metadata remain in the veterinary/professional layer.

Owner handouts

0
No owner handouts linked yet.

Official label / PI

0
No official label or package insert links yet.

SPL

1

FOI

0
No FOI links yet.

Meticorten®

SPL · SPL

FDA Structured Product Label

Meticorten®

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Intervet, Inc.
NADA
9963
Status
RX
Form
Liquid (Suspension)
Route
Intramuscular
Species
Dog • Horse • Cat
Composition / specifications
Each milliliter of sterile aqueous suspension contains 10 to 40 milligrams of prednisone.

Horses

Indication
It is used for conditions requiring an anti-inflammatory agent.
Dosage
100 to 400 milligrams intramuscularly, repeating if necessary. If no response is observed after 3 to 4 days of therapy, reevaluate diagnosis.
Limitations
Do not use in viral infections. Except in emergency therapy, do not use in animals with tuberculosis, chronic nephritis, or Cushings's disease. With infections, use appropriate antibacterial therapy with and for at least 3 days after discontinuance of use and disappearance of all signs of infection. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta and metritis. Not for use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Dogs

Indication
It is used for conditions requiring an anti-inflammatory agent.
Dosage
0.25 to 1.0 milligram per pound of body weight for 3 to 5 days or until a response is noted. Treatment may be continued with an orally administered dose.
Limitations
Do not use in viral infections. Except in emergency therapy, do not use in animals with tuberculosis, chronic nephritis, or Cushings's disease. With infections, use appropriate antibacterial therapy with and for at least 3 days after discontinuance of use and disappearance of all signs of infection. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta and metritis. Not for use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Cats

Indication
It is used for conditions requiring an anti-inflammatory agent.
Dosage
0.25 to 1.0 milligram per pound of body weight for 3 to 5 days or until a response is noted. Treatment may be continued with an orally administered dose.
Limitations
Do not use in viral infections. Except in emergency therapy, do not use in animals with tuberculosis, chronic nephritis, or Cushings's disease. With infections, use appropriate antibacterial therapy with and for at least 3 days after discontinuance of use and disappearance of all signs of infection. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta and metritis. Not for use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Veterinary reference (advanced)

Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.

At a Glance

Quick facts and links to official labeling and safety signals.

Data freshness
  • Reference facts: Source Roxee | Refreshed Aug 6, 2026, 7:46 PM UTC
    The reference fact projection used for browse cards and quick facts.
  • Animal Drugs @ FDA: Source FDA | Refreshed Aug 6, 2026, 7:46 PM UTC
    Applications/products are imported from FDA export data.
  • Animal Drugs @ FDA previews: Source FDA | Refreshed Feb 9, 2026, 3:05 AM UTC
    Label highlights/doc links are fetched from FDA preview endpoints.
  • openFDA reaction terms: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
  • openFDA case summaries: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
Official (FDA)
Identity: Generic ingredient • No FDA branded products linked
No official FDA brand rows linked yet for this ingredient.
Case-reported brands (openFDA): MSK
Catalog species: Both FDA-labeled species: Cat, Dog, Horse
Rx/OTC: RX
Form/route: Liquid (Suspension) Intramuscular
Applications: NADA 9963
Documents: • SPL: 1 Label highlights Official documents
Safety (openFDA)
Top reactions: Dog 260 Cat 70 View
Case summaries: 66 (showing 8) View
openFDA reports are unverified and do not prove causation.

Explore
Related conditions: Dystocia Metritis
Linked using: Fda_Label (0.95), Fda_Label (0.95)

Diagnosis Codes

Diagnosis-code mappings are not available for this medication yet.

Counseling and Monitoring Highlights

Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.

Owner-facing counseling points
  • Avoid combining with NSAIDs. Use caution with diabetes, infections, GI ulcer history. (Contraindication, High)
Top reaction signals
Unsteady walking (ataxia) (1) Loss of appetite (1) Blood in urine (1) Blood in faeces (1) Aspiration pneumonia (1) Application site dry skin (1) Anaphylaxis (1) Anaemia NOS (1)

Identifiers & Packages

Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.

Identifiers
NADA: 9963

Data Sources & Change Log

Every non-trivial field is expected to include provenance and update timestamps.

Official 8 Clinical 4 Manufacturer 0 Marketing 0
Current Field Facts
  • side_effects: Increased thirst/urination, increased appetite, panting, GI upset. Long-term use: immune suppression and other risks. (Clinical, 2026-04-11)
  • storage_handling: Store at room temperature. (Clinical, 2026-04-12)
  • storage_handling: Store at room temperature. (Clinical, 2026-04-11)
  • storage_handling: Store at room temperature. (Clinical, 2026-02-12)
  • contraindications: Avoid combining with NSAIDs. Use caution with diabetes, infections, GI ulcer history. (Official, 2026-04-12)
  • contraindications: Avoid combining with NSAIDs. Use caution with diabetes, infections, GI ulcer history. (Official, 2026-04-11)
  • contraindications: Avoid combining with NSAIDs. Use caution with diabetes, infections, GI ulcer history. (Official, 2026-02-12)
  • side_effects: Increased thirst/urination, increased appetite, panting, GI upset. Long-term use: immune suppression and other risks. (Official, 2026-04-12)
  • side_effects: Increased thirst/urination, increased appetite, panting, GI upset. Long-term use: immune suppression and other risks. (Official, 2026-02-12)
  • usage: Corticosteroid used for inflammatory and immune-mediated conditions. (Official, 2026-04-12)
  • usage: Corticosteroid used for inflammatory and immune-mediated conditions. (Official, 2026-04-11)
  • usage: Corticosteroid used for inflammatory and immune-mediated conditions. (Official, 2026-02-12)
Recent Revisions
  • side_effects updated 2026-04-12 10:05 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-04-12 10:05 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-04-12 10:05 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-04-11 10:05 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-04-11 10:05 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-04-11 10:05 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-02-12 19:40 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-02-12 19:40 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-02-12 19:40 by etl_backfill • Backfilled from existing medication fields

FDA Products & Applications (Animal Drugs @ FDA)

Official sponsor/proprietary-name/application-status records linked by active ingredient.

Product Sponsor Application Status Published
Meticorten®
RX
Prednisone
Liquid (Suspension) Intramuscular
Intervet, Inc. NADA 9963 Approved Jun 1, 2016

Data source: FDA Animal Drugs @ FDA (public search export).

What It's For (FDA Label Highlights)

Extracted from FDA Animal Drugs @ FDA product labeling. Always confirm details with your veterinarian.

Species: Dog • Horse • Cat
Composition / specifications
Each milliliter of sterile aqueous suspension contains 10 to 40 milligrams of prednisone.
Horses
Indication
It is used for conditions requiring an anti-inflammatory agent.
Dosage
100 to 400 milligrams intramuscularly, repeating if necessary. If no response is observed after 3 to 4 days of therapy, reevaluate diagnosis.
Limitations
Do not use in viral infections. Except in emergency therapy, do not use in animals with tuberculosis, chronic nephritis, or Cushings's disease. With infections, use appropriate antibacterial therapy with and for at least 3 days after discontinuance of use and disappearance of all signs of infection. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta and metritis. Not for use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Dogs
Indication
It is used for conditions requiring an anti-inflammatory agent.
Dosage
0.25 to 1.0 milligram per pound of body weight for 3 to 5 days or until a response is noted. Treatment may be continued with an orally administered dose.
Limitations
Do not use in viral infections. Except in emergency therapy, do not use in animals with tuberculosis, chronic nephritis, or Cushings's disease. With infections, use appropriate antibacterial therapy with and for at least 3 days after discontinuance of use and disappearance of all signs of infection. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta and metritis. Not for use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Cats
Indication
It is used for conditions requiring an anti-inflammatory agent.
Dosage
0.25 to 1.0 milligram per pound of body weight for 3 to 5 days or until a response is noted. Treatment may be continued with an orally administered dose.
Limitations
Do not use in viral infections. Except in emergency therapy, do not use in animals with tuberculosis, chronic nephritis, or Cushings's disease. With infections, use appropriate antibacterial therapy with and for at least 3 days after discontinuance of use and disappearance of all signs of infection. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta and metritis. Not for use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Usage

Corticosteroid used for inflammatory and immune-mediated conditions.

Source: FDA Animal Drugs @ FDA • Reference

Contraindications

Avoid combining with NSAIDs. Use caution with diabetes, infections, GI ulcer history.

Side Effects

Increased thirst/urination, increased appetite, panting, GI upset. Long-term use: immune suppression and other risks.

Source: FDA openFDA • Reference

Top Reported Reactions (openFDA)

De-duplicated reaction terms grouped by body system from FDA openFDA reports (not verified; does not prove causation).

Digestive
Loss of appetite (1) • Dog Appetite disorder NOS (1) • Dog

Showing top 5 for Digestive.

Skin & allergy
Hair loss (1) • Dog Application site hair loss (1) • Cat Alopecia local (1) • Dog

Showing top 5 for Skin & allergy.

Neurologic
Unsteady walking (1) • Dog

Showing top 5 for Neurologic.

Behavior
Behavioral disorder (1) • Cat Anxiety (1) • Dog

Showing top 5 for Behavior.

Other
Blood in urine (1) • Dog Blood in faeces (1) • Dog Blepharitis (1) • Dog Balance impaired (1) • Cat Atopic allergy NOS (1) • Dog
Show more (19)
Aspiration pneumonia (1) • Dog Arthritis (1) • Dog Application site scab (1) • Cat Application site dry skin (1) • Dog Anaphylaxis (1) • Dog Anaemia NOS (1) • Dog Allergic skin reaction (1) • Dog Agonal breathing (1) • Cat Addison's disease (1) • Dog Abnormal urine odour (1) • Dog Abnormal ultrasound finding (1) • Dog Abnormal radiograph finding (1) • Cat Abnormal pupil light reflex (1) • Cat Abnormal menace reflex test (1) • Cat Abnormal histology NOS (1) • Dog Abnormal cytology (1) • Dog Abdominal pain (1) • Dog Abdominal oedema (1) • Cat Abdominal cavity disorder NOS (1) • Dog

Showing top 5 for Other.

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Adverse Event Case Summaries (openFDA)

These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.

Dog, Schnauzer - Miniature, Male, 5 year, 10.16 kilogram • Drug: MSK, Unassigned, Oral • Reactions: Lameness, Wobbliness, Tiredness (lethargy), Unable to walk, Weakness… • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2026-US-014449
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 5.00 Year
  • Weight: 10.160 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Oral
  • Form: Unassigned
Reactions Reported:
Lameness Wobbliness Tiredness (lethargy) Unable to walk Weakness Fever Immune-mediated polyarthritis Gastritis Abdominal cavity disorder NOS Abnormal ultrasound finding Hyperproteinaemia Lymphopenia Eosinopenia Medication error NOS
Outcomes: Ongoing

Dog, Chihuahua, Female, 12 year, 4.173 kilogram • Drug: MSK, Unassigned, Oral • Reactions: Luxation/subluxation, Lack of efficacy - NOS, Joint swelling, Bone and joint disorder NOS, Pain NOS… • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2026-US-013826
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Female
  • Age: 12.00 Year
  • Weight: 4.173 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Oral
  • Form: Unassigned
Reactions Reported:
Luxation/subluxation Lack of efficacy - NOS Joint swelling Bone and joint disorder NOS Pain NOS Lameness Hyperextension
Outcomes: Ongoing

Dog, ['Shepherd Dog - Australian', 'Dog (unknown)'], Male, 10.4 year, 41.05 kilogram • Drug: MSK, Unassigned, Oral • Reactions: Lack of efficacy - NOS, Low thyroxine • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2026-US-013823
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 10.40 Year
  • Weight: 41.050 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Oral
  • Form: Unassigned
Reactions Reported:
Lack of efficacy - NOS Low thyroxine
Outcomes: Ongoing

Dog, Retriever - Labrador, Male, 10 year, 28.576 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Limping, Limb weakness, Cough, Neurological signs NOS, Wobbliness… • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2026-US-013484
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 10.00 Year
  • Weight: 28.576 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
  • Form: Unassigned
Reactions Reported:
Limping Limb weakness Cough Neurological signs NOS Wobbliness Collapse NOS Fever Joint pain Joint swelling Gait abnormality Tense muscles Elevated alanine aminotransferase Elevated serum alkaline phosphatase Hyperglycaemia Neutrophilia Abnormal radiograph finding Immune-mediated polyarthritis Blood in faeces Medication error NOS
Outcomes: Ongoing

Dog, Crossbred Canine/dog, Male, 12 year, 28.168 kilogram • Drug: MSK, Unassigned, Oral • Reactions: Vocalisation, Hind limb ataxia, Inappropriate defecation, Behavioral disorder (unspecified), Muscle stiffness… • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2026-US-013182
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 12.00 Year
  • Weight: 28.168 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Oral
  • Form: Unassigned
Reactions Reported:
Vocalisation Hind limb ataxia Inappropriate defecation Behavioral disorder (unspecified) Muscle stiffness Injection site pain
Outcomes: Ongoing

Dog, Poodle - Standard, Female, 6 year, 18.552 kilogram • Drug: MSK, Unassigned, Oral • Reactions: Drooling, Nausea, Injection site swelling • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2026-US-014481
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Female
  • Age: 6.00 Year
  • Weight: 18.552 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Oral
  • Form: Unassigned
Reactions Reported:
Drooling Nausea Injection site swelling
Outcomes: Ongoing

Dog, Pit Bull, Female, 8.58 year • Drug: MSK, Unknown • Reactions: Cough, Death by euthanasia, Low platelet count, Pulmonary oedema, Coughing up blood… • Outcome: Euthanized

  • Report ID: USA-USFDACVM-2026-US-014254
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Female
  • Age: 8.58 Year
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
Reactions Reported:
Cough Death by euthanasia Low platelet count Pulmonary oedema Coughing up blood Respiratory distress
Outcomes: Euthanized

Dog, Shepherd Dog - Australian, Male, 5.83 year, 25.85 kilogram • Drug: MSK, Unassigned, Oral, Dose: 9.8230 Milligram per animal, Frequency: 12 per hour • Reactions: Partial lack of efficacy, Skin lesion NOS, Inappropriate elimination NOS, Polyuria, Polydipsia… • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2026-US-013216
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 5.83 Year
  • Weight: 25.850 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Oral
  • Form: Unassigned
  • Dose: 9.8230 Milligram per animal
  • Frequency: 12 per hour
Reactions Reported:
Partial lack of efficacy Skin lesion NOS Inappropriate elimination NOS Polyuria Polydipsia Medication error NOS Licking Abnormal histology NOS
Outcomes: Ongoing

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Overdose Information

No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.

Storage & Handling

Store at room temperature.

Share Your Thoughts

Let others know your experience or advice regarding this medication.

This medication has not been reviewed by a veterinarian yet.